NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/11/2025
Back to search
Official data from USPTO
OXB SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OXB SOLUTIONS
ST13
US500000097361213Class
5, 40, 42, 44, 45
Filing
97361213
Registration
7683507
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
02/11/2025
Trademark type
Word
Nice classes
5, 40, 42, 44, 45
Filing date
04/13/2022
Registration date
02/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/11/2025
Last transaction
02/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
11
Owner location
Oxford, GB
Examiner
HAYES, GINA
Law office
L30
Current location
INTENT TO USE SECTION
Holders and representatives
Holders
Oxford BioMedica Plc
Representatives
Roberta S. Bren MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 5Class 40Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsbiological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseasesvaccines; pharmaceutical substances and preparations for the treatment or prevention of cancerinfectious diseasefungal diseasesdisease caused by bacteriaviruses and parasiteseye diseasediseases of the central and peripheral nervous systemscardiovascular diseasediseases affecting the immune systeminflammatory diseasesinherited diseasesingle gene disordersdiseases of the mouthteethskinhair and earbone and blood diseases and reproductive system disorders; gene therapy productsnanoparticlesviral vectorsretroviral vectorslentiviral vectors and non-viral vectors for the delivery of genes to cellsall for medical purposes; vaccine manufacturing preparations; viral vaccinesviral vectorretroviral vectorlentiviral vector and non-viral vector preparations for the treatment or prevention of cancerinfectious diseasefungal diseasesdisease caused by bacteriaviruses and parasiteseye diseasediseases of the central and peripheral nervous systemscardiovascular diseasediseases affecting the immune systeminflammatory diseasesinherited diseasesingle gene disordersdiseases of the mouthteethskinhair and earbone and blood diseases and reproductive system disorders; biochemical and chemical products for use in medical scienceviral vectors; pharmaceutical and biochemical preparations for the treatment or prevention of cancerinfectious diseasefungal diseasesdisease caused by parasiteseye diseasediseases of the central and peripheral nervous systemscardiovascular diseasediseases affecting the immune systeminflammatory diseasesinherited diseasesingle gene disordersdiseases of the mouthteethskinhair and earbone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes
Class 40
Custom manufacture of products relating to biotechnology; manufacture of gene therapyviralretrovirallentiviral and non-viral preparations and biopharmaceutical products; manufacture of biotechnology products; manufacture of viral and non-viral vectors; manufacture of vaccines
Class 42
Scientific research and development services in the field of biochemistry and genetic engineering; biochemistry engineering; genetic engineering; design of manufacturing facilities; quality control for others; scientific and technological servicestesting and validation services in the fields of gene and cell therapy and biotechnology; product development consultancy in the field of nanotechnologygene therapy and vector-based delivery systems; medical and scientific laboratory services; scientific and technological servicesscientific researchdevelopment and analysis in the fields of gene and cell therapy and biotechnology; industrial analysis servicesanalysis of viral vectors and gene therapy products to assure compliance with medical and pharmaceutical industry standards; provision of scientific information in the field of biotechnologygene therapy and cell therapy; research and scientific analysis relating to drug discovery and development for others; scientific research in the nature of conducting clinical trials for others; manufacture of viral vectorsgene therapy and cell therapy products; product and manufacturing process development in the fields of biotechnologygene therapy and cell therapy
Class 44
Medical diagnostic testing; information relating to pharmaceuticalsbioceuticals and advanced therapy medicinal products; providing medical information to medical professionals in the form of reports in the field of biotechnologygene therapy and cell therapy; consultancyadvice and information in the field of clinical trialshealthcarepharmaceuticals and advanced therapy medicinal products; medical advisory services relating to vaccination regimes; medical advisory services relating to the treatmentrelief and/or prevention of cancerinfectious diseasesfungal diseasesdisease caused by parasiteseye diseasediseases of the central and peripheral nervous systemscardiovascular diseasediseases affecting the immune systeminflammatory diseasessingle gene disordersdiseases of the mouthteethskinhair and earbone and blood diseasesreproductive system disorderspharmaceutical and biochemical preparations for contraceptive purposesin humans and animals
Class 45
Preparation and review of reports for regulatory approval of pharmaceuticals and bioceuticals; licensing of intellectual property; regulatory compliance consulting in the field of chemistry manufacturing and controls (CMC) activities
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/11/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
01/17/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
06/24/2024
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
06/24/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/26/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/31/2023
PUBO
PUBLISHED FOR OPPOSITION
10/31/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/14/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/14/2023
ALIE
ASSIGNED TO LIE
09/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/28/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/03/2023
GNRT
NON-FINAL ACTION E-MAILED
02/03/2023
CNRT
NON-FINAL ACTION WRITTEN
02/03/2023
DOCK
ASSIGNED TO EXAMINER
01/31/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/19/2022
NWAP
NEW APPLICATION ENTERED
04/16/2022
Continuous trademark protection
Get notified about every new filing that threatens OXB SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.